Advisor Group’s AngioDynamics ANGO Stock Holding History

Advisor Group’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$48K	Sell	2,945 -1,076	-27%	-$16.4K	﹤0.01%	3434
2019 Q3	$74K	Buy	4,021 +471	+13%	+$9.21K	﹤0.01%	3107
2019 Q2	$70K	Sell	3,550 -297	-8%	-$6.05K	﹤0.01%	3125
2019 Q1	$87K	Buy	3,847 +442	+13%	+$9.6K	﹤0.01%	2981
2018 Q4	$68K	Buy	3,405 +601	+21%	+$12.4K	﹤0.01%	2966
2018 Q3	$61K	Buy	+2,804	New	+$62.3K	﹤0.01%	3138
2018 Q1	–	Sell	-1,000	Closed	-$17K	–	4936
2017 Q4	$17K	Hold	1,000	–	–	﹤0.01%	3793
2017 Q3	$17K	Sell	1,000 -1,282	-56%	-$21.5K	﹤0.01%	3639
2017 Q2	$37K	Buy	2,282 +2,210	+3,069%	+$34.9K	﹤0.01%	3040
2017 Q1	$1K	Buy	+72	New	+$1.2K	﹤0.01%	4496

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Advisor Group's ANGO Position: Q4 2019 in Review

Advisor Group reduced its AngioDynamics (ANGO) stake by 27% in Q4 2019, selling an estimated $16.4K and leaving 2,945 shares worth $48K. The position accounts for ﹤0.01% of the portfolio, ranked #3434.

Advisor Group first reported a position in ANGO in Q1 2017 and has held it in 10 quarters since. The position peaked at $87K in Q1 2019. 157 funds tracked by Wall St. Rank hold ANGO as of Q4 2019.

Advisor Group held 2,945 shares of AngioDynamics worth $48K as of Q4 2019.
Advisor Group sold 1,076 AngioDynamics shares in Q4 2019, an estimated $16.4K.
AngioDynamics made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3434 holding.
Advisor Group first reported a position in AngioDynamics in Q1 2017 and has held it in 10 quarters since.
Advisor Group's AngioDynamics position peaked at $87K in Q1 2019.
157 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.